Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Patterns of Antipsychotic Prescribing by Physicians to Young Children.

Huskamp HA, Horvitz-Lennon M, Berndt ER, Normand ST, Donohue JM.

Psychiatr Serv. 2016 Dec 1;67(12):1307-1314.

PMID:
27417891
2.

Olanzapine Treatment of Adolescent Rats Alters Adult D2 Modulation of Cortical Inputs to the Ventral Striatum.

Brooks JM, O'Donnell P, Frost DO.

Int J Neuropsychopharmacol. 2016 May 12. pii: pyw034. doi: 10.1093/ijnp/pyw034. [Epub ahead of print]

3.

Delayed yet persistent effects of daily risperidone on activity in developing rats.

Stevens RM, Gannon MA, Griffith MS, Bardgett ME.

Behav Pharmacol. 2016 Aug;27(5):460-9. doi: 10.1097/FBP.0000000000000230.

PMID:
26960160
4.
5.

Early-life risperidone administration alters maternal-offspring interactions and juvenile play fighting.

Gannon MA, Brown CJ, Stevens RM, Griffith MS, Marczinski CA, Bardgett ME.

Pharmacol Biochem Behav. 2015 Mar;130:90-6. doi: 10.1016/j.pbb.2015.01.007.

6.

Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine.

Vucicevic L, Misirkic-Marjanovic M, Paunovic V, Kravic-Stevovic T, Martinovic T, Ciric D, Maric N, Petricevic S, Harhaji-Trajkovic L, Bumbasirevic V, Trajkovic V.

Autophagy. 2014;10(12):2362-78. doi: 10.4161/15548627.2014.984270.

7.

State Investments in Psychiatric Innovation: Investigating Unmeasured State Factors.

Domino ME, Beadles CA.

Health Serv Outcomes Res Methodol. 2014 Jun 1;14(1-2):34-53.

8.

The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states.

Stein BD, Leckman-Westin E, Okeke E, Scharf DM, Sorbero M, Chen Q, Chor KH, Finnerty M, Wisdom JP.

J Child Adolesc Psychopharmacol. 2014 Sep;24(7):374-81. doi: 10.1089/cap.2014.0008.

9.

Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effects.

Remington G, Hahn M.

J Psychiatry Neurosci. 2014 Jan;39(1):E1-2. doi: 10.1503/jpn.120205. No abstract available.

11.

Adult rats treated with risperidone during development are hyperactive.

Bardgett ME, Franks-Henry JM, Colemire KR, Juneau KR, Stevens RM, Marczinski CA, Griffith MS.

Exp Clin Psychopharmacol. 2013 Jun;21(3):259-67. doi: 10.1037/a0031972.

12.

Measuring disparities across the distribution of mental health care expenditures.

Le Cook B, Manning W, Alegria M.

J Ment Health Policy Econ. 2013 Mar;16(1):3-12.

13.

Antipsychotic treatment patterns and aggressive behavior among adolescents in residential facilities.

Miller L, Riddle MA, Pruitt D, Zachik A, dosReis S.

J Behav Health Serv Res. 2013 Jan;40(1):97-110. doi: 10.1007/s11414-012-9314-y.

14.

Review of the operational definition for first-episode psychosis.

Breitborde NJ, Srihari VH, Woods SW.

Early Interv Psychiatry. 2009 Nov;3(4):259-65. doi: 10.1111/j.1751-7893.2009.00148.x. Review.

15.

Ten-year trends in quality of care and spending for depression: 1996 through 2005.

Fullerton CA, Busch AB, Normand SL, McGuire TG, Epstein AM.

Arch Gen Psychiatry. 2011 Dec;68(12):1218-26. doi: 10.1001/archgenpsychiatry.2011.146.

16.

Antipsychotic treatment among youth in foster care.

Dosreis S, Yoon Y, Rubin DM, Riddle MA, Noll E, Rothbard A.

Pediatrics. 2011 Dec;128(6):e1459-66. doi: 10.1542/peds.2010-2970.

17.

Clinical characteristics of children receiving antipsychotic medication.

Findling RL, Horwitz SM, Birmaher B, Kowatch RA, Fristad MA, Youngstrom EA, Frazier TW, Axelson D, Ryan N, Demeter CA, Depew J, Fields B, Gill MK, Deyling EA, Rowles BM, Arnold LE.

J Child Adolesc Psychopharmacol. 2011 Aug;21(4):311-9. doi: 10.1089/cap.2010.0138.

18.

Does managed care affect the diffusion of psychotropic medications?

Domino ME.

Health Econ. 2012 Apr;21(4):428-43. doi: 10.1002/hec.1723.

19.

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V.

Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.

20.

Increasing off-label use of antipsychotic medications in the United States, 1995-2008.

Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS.

Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):177-84. doi: 10.1002/pds.2082.

Items per page

Supplemental Content

Support Center